The market for full slide imaging was valued at US$ 721.55 million in 2021 and is anticipated to grow at a CAGR of 12.4% from 2022 to 2028 to reach US$ 1,627.68 million. The prevalence of diseases like cancer is rising, and more labs are adopting digital pathology to promote productivity. These factors are driving the significant growth of the worldwide whole slide imaging market. Furthermore, the market is anticipated to rise faster as a result of technical developments in full slide imaging. But there are some significant factors that are anticipated to restrain the growth of the worldwide whole slide imaging market, including the high cost of whole slide imaging systems and strict regulatory clearances.
Click Here to Get a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/5264
Regional Insights
The worldwide whole slide imaging market is divided into five regions based on geography: North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa.
Due to the rising cancer incidence and increasing usage of digital pathology to increase lab efficiency, North America is predicted to gain the largest market share throughout the projection period. For instance, the American Cancer Society predicts that in 2022 there will be around 1.9 million new instances of cancer and 609,360 cancer-related deaths in the United States. It is projected that a large rise in cancer incidence will enhance the need for diagnostic laboratories and speed up market growth.
Due to the region’s growing population, which is more susceptible to numerous diseases, and an increase in drug discovery efforts, particularly in India, Asia Pacific is also anticipated to experience rapid growth in the worldwide whole slide imaging market. For instance, the Indian government intended to launch a new push for homegrown drug discovery in August 2020 and set up a special (R&D) research & development department to manage the initiatives. India is the third-largest supplier of medications in the world and is home to over 3,000 pharmaceutical businesses as well as a network of over 10,500 production facilities.
Market Drivers
Over the course of the projection period, it is anticipated that the usage of digital pathology to increase lab productivity would increase. Glass slides are scanned to create digital images as part of the revolutionary technology known as whole slide imaging. It is a brand-new imaging technique that pathology departments all around the world are using. For instance, new uses for digital pathology have been made possible by the U.S. Food and Drug Administration’s (USFDA) approval of a few digital whole slide imaging systems for surgical pathology primary diagnosis.
Over the projected period, an increase in cancer incidence is anticipated to boost market expansion for whole slide imaging. For instance, entire slide imaging, which examines many techniques and applications to improve clinical care and cancer detection, is one of the developing topics of digital pathology. The World Health Organization (WHO) reports that cancer was the biggest cause of death globally in 2020, accounting for almost 10 million deaths, or roughly one in every six. Lung, breast, prostate, colon, and rectum cancers are the most prevalent types of cancer.
Market Opportunities
The overall slide imaging industry is likely to offer considerable development potential for competitors due to the increasing popularity of virtual/digital slides over real slides. For example, virtual/digital slides may produce accurate diagnostic results quickly while also reducing human error, hence pathology laboratories are increasingly implementing this technology to increase lab productivity. Olympus Corp. introduced the SLIDEVIEW VS200 in October 2019. It’s a research slide scanner that can record excellent digital slides and enable sophisticated quantitative image analysis of samples pertaining to many applications.
Whole slide imaging market participants could benefit from lucrative development prospects due to the growing applications of whole slide imaging (digital pathology). For instance, pathologists can operate remotely in areas where the COVID-19 Pandemic has severely restricted logistics. This is made possible by whole-slide imaging.
Market Trends
In recent years, pathology and medical imaging have seen significant change thanks to artificial intelligence (AI). The diagnostic process can be improved by digitalized slides or photographs. Utilizing digital slides or photos for workflow and diagnostic applications is made simpler by AI. As a result, pathology laboratories all over the globe are utilising more cutting-edge whole slide imaging techniques, and this trend is anticipated to persist over the course of the forecast period, fueling the expansion of the global whole slide imaging market.
The rising integration of medical services and digital pathology platforms, which has led to an increase in popularity and acceptability of digital consultation, is likely to drive significant development in the worldwide whole slide imaging market over the course of the forecast period. Due to the widespread use of immunohistochemistry by pharma and biotech businesses, whole slide imaging is also becoming more significant.
Market Restraints
The expansion of the worldwide whole slide imaging market is anticipated to be hampered by the high cost of whole slide imaging instruments or systems. For instance, in clinical practise, the cost of whole slide imaging includes not only the usual direct expenditures but also indirect costs such as pre-scan, scan, and post-scan costs. An initial capital outlay of about US$ 2 million (for hardware and software), a yearly direct expense of about $ 10,000 for the memory used to store the digital photos, and a yearly indirect expense of about US$ 650,000 for support staff.
The worldwide whole slide imaging market is anticipated to have slow expansion due to strict regulatory framework. Scanners and other digital pathology-related equipment are governed by the US Food and Drug Administration since they are deemed medical devices in the US (USFDA).
Market Segmentation
The Technology, Application, End-User, and Region segments are included in the worldwide whole slide imaging market study.
The market is divided into Scanners, IT Infrastructure, Viewers, and Image Management Systems based on technology. In particular, the scanners segment is anticipated to dominate the worldwide whole slide imaging market throughout the course of the forecast period. This is due to the growing popularity of technologically sophisticated whole slide imaging equipment and devices, since scanners can quickly scan thousands of slides.
Due to the growing acceptance of digital pathology throughout the world, the IT infrastructure segment is also anticipated to have substantial development in the near future. For the complete adoption of digital workflow in hospitals and laboratories, especially in a safe, dependable, and scalable way, IT infrastructure is crucial.
The whole slide imaging market is divided into Telepathology, Cytopathology, Immunohistochemistry, and Hematopathologists based on Application. Out of these, the Telepathology Segment is anticipated to lead the market during the course of the projected period, and this is due to the global COVID-19 epidemic. The epidemic has given pathology laboratories and departments a completely new perspective on how to assess slides remotely. The epidemic has expanded telepathology use all across the world.
Due to the growing population base that is more susceptible to different diseases, the cytopathology segment is also anticipated to have considerable expansion in the near future. In order to determine the origin and kind of a disease, a specialised diagnostic procedure called cytopathology is utilised to study individual cells removed from tissues.
The market is divided into three categories based on end-users: education, research, and clinical. Due to the rise in global research and development activities, the Research Segment is predicted to have a monopoly on the market throughout the forecast period. Researchers were able to investigate, examine, and alter the digital pictures of specimens that were acquired from pathology slides thanks to the development of whole slide imaging.
Due to the growing interest in or use of digital pathology, the clinical segment is also anticipated to experience considerable growth in the near future. The clinical uses of digital pathology with whole-slide imaging are many.
Key Developments
A contract allowing pathology at Institut Curie to be digitally archived was signed by Sectra AB and Institut Curie in May 2021. The Sectra pathology package provides cases, digital tools, and AI applications to the pathologists at Institut Curie.
The University of Chicago set up the brand-new Olympus VS200 Slideview Research Slide Scanner in May 2021 in partnership with Olympus Corporation.
In order to provide cutting-edge fluorescence multiplexing solutions, Olympus Corporation and Ultivue struck a co-marketing agreement in December 2019 for the latter’s SLIDEVIEW VS200 slide scanner and Ultivue UltiMapper reagents.
Key Companies Insights
The entire slide imaging market is really cutthroat. This is explained by the fact that virtual slides are becoming more and more popular in comparison to actual slides, and as a result, market participants are concentrating on introducing new goods.
Among others, Ventana Medical Systems Inc., 3Dhistech, Mikroscan Technologies Inc., Visiopharm, Philips Healthcare, Definiens AG, Olympus Corporation, Hamamatsu Photonics KK, Nikon Corporation, Indica Labs, Leica Biosystems GmbH, and Inspirata are some of the major players in the world market for whole slide imaging.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/5264
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Whole Slide Imaging Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Whole Slide Imaging Industry Impact
Chapter 2 Global Whole Slide Imaging Competition by Types, Applications, and Top Regions and Countries
2.1 Global Whole Slide Imaging (Volume and Value) by Type
2.3 Global Whole Slide Imaging (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Whole Slide Imaging Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Whole Slide Imaging Market Analysis
Chapter 6 East Asia Whole Slide Imaging Market Analysis
Chapter 7 Europe Whole Slide Imaging Market Analysis
Chapter 8 South Asia Whole Slide Imaging Market Analysis
Chapter 9 Southeast Asia Whole Slide Imaging Market Analysis
Chapter 10 Middle East Whole Slide Imaging Market Analysis
Chapter 11 Africa Whole Slide Imaging Market Analysis
Chapter 12 Oceania Whole Slide Imaging Market Analysis
Chapter 13 South America Whole Slide Imaging Market Analysis
Chapter 14 Company Profiles and Key Figures in Whole Slide Imaging Business
Chapter 15 Global Whole Slide Imaging Market Forecast (2022-2028)
Chapter 16 Conclusions
Research Methodology
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/5264
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Mr Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837